In prostate cancer, Owens and colleagues demonstrated a unique mechanism by which PRMT5 and cofactor pICln coordinate H4R3me2s-mediated transcriptional activation at DDR promoters in response to irradiation (14). This evidence concerns the gene PRMT5 and prostate carcinoma.